Sensitivity of mitochondrial transcription and resistance of RNA polymerase II dependent nuclear transcription to antiviral ribonucleosides.
Ribonucleoside analogues have potential utility as anti-viral, -parasitic, -bacterial and -cancer agents. However, their clinical applications have been limited by off target effects. Development of antiviral ribonucleosides for treatment of hepatitis C virus (HCV) infection has been hampered by app...
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS Pathogens |
Online Access: | http://europepmc.org/articles/PMC3499576?pdf=render |
id |
doaj-b319ca8392e34c9a89590b29d3f91226 |
---|---|
record_format |
Article |
spelling |
doaj-b319ca8392e34c9a89590b29d3f912262020-11-25T02:17:29ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742012-01-01811e100303010.1371/journal.ppat.1003030Sensitivity of mitochondrial transcription and resistance of RNA polymerase II dependent nuclear transcription to antiviral ribonucleosides.Jamie J ArnoldSuresh D SharmaJoy Y FengAdrian S RayEric D SmidanskyMaria L KireevaAesop ChoJason PerryJennifer E VelaYeojin ParkYili XuYang TianDarius BabusisOna BarauskusBlake R PetersonAverell GnattMikhail KashlevWeidong ZhongCraig E CameronRibonucleoside analogues have potential utility as anti-viral, -parasitic, -bacterial and -cancer agents. However, their clinical applications have been limited by off target effects. Development of antiviral ribonucleosides for treatment of hepatitis C virus (HCV) infection has been hampered by appearance of toxicity during clinical trials that evaded detection during preclinical studies. It is well established that the human mitochondrial DNA polymerase is an off target for deoxyribonucleoside reverse transcriptase inhibitors. Here we test the hypothesis that triphosphorylated metabolites of therapeutic ribonucleoside analogues are substrates for cellular RNA polymerases. We have used ribonucleoside analogues with activity against HCV as model compounds for therapeutic ribonucleosides. We have included ribonucleoside analogues containing 2'-C-methyl, 4'-methyl and 4'-azido substituents that are non-obligate chain terminators of the HCV RNA polymerase. We show that all of the anti-HCV ribonucleoside analogues are substrates for human mitochondrial RNA polymerase (POLRMT) and eukaryotic core RNA polymerase II (Pol II) in vitro. Unexpectedly, analogues containing 2'-C-methyl, 4'-methyl and 4'-azido substituents were inhibitors of POLRMT and Pol II. Importantly, the proofreading activity of TFIIS was capable of excising these analogues from Pol II transcripts. Evaluation of transcription in cells confirmed sensitivity of POLRMT to antiviral ribonucleosides, while Pol II remained predominantly refractory. We introduce a parameter termed the mitovir (mitochondrial dysfunction caused by antiviral ribonucleoside) score that can be readily obtained during preclinical studies that quantifies the mitochondrial toxicity potential of compounds. We suggest the possibility that patients exhibiting adverse effects during clinical trials may be more susceptible to damage by nucleoside analogs because of defects in mitochondrial or nuclear transcription. The paradigm reported here should facilitate development of ribonucleosides with a lower potential for toxicity.http://europepmc.org/articles/PMC3499576?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jamie J Arnold Suresh D Sharma Joy Y Feng Adrian S Ray Eric D Smidansky Maria L Kireeva Aesop Cho Jason Perry Jennifer E Vela Yeojin Park Yili Xu Yang Tian Darius Babusis Ona Barauskus Blake R Peterson Averell Gnatt Mikhail Kashlev Weidong Zhong Craig E Cameron |
spellingShingle |
Jamie J Arnold Suresh D Sharma Joy Y Feng Adrian S Ray Eric D Smidansky Maria L Kireeva Aesop Cho Jason Perry Jennifer E Vela Yeojin Park Yili Xu Yang Tian Darius Babusis Ona Barauskus Blake R Peterson Averell Gnatt Mikhail Kashlev Weidong Zhong Craig E Cameron Sensitivity of mitochondrial transcription and resistance of RNA polymerase II dependent nuclear transcription to antiviral ribonucleosides. PLoS Pathogens |
author_facet |
Jamie J Arnold Suresh D Sharma Joy Y Feng Adrian S Ray Eric D Smidansky Maria L Kireeva Aesop Cho Jason Perry Jennifer E Vela Yeojin Park Yili Xu Yang Tian Darius Babusis Ona Barauskus Blake R Peterson Averell Gnatt Mikhail Kashlev Weidong Zhong Craig E Cameron |
author_sort |
Jamie J Arnold |
title |
Sensitivity of mitochondrial transcription and resistance of RNA polymerase II dependent nuclear transcription to antiviral ribonucleosides. |
title_short |
Sensitivity of mitochondrial transcription and resistance of RNA polymerase II dependent nuclear transcription to antiviral ribonucleosides. |
title_full |
Sensitivity of mitochondrial transcription and resistance of RNA polymerase II dependent nuclear transcription to antiviral ribonucleosides. |
title_fullStr |
Sensitivity of mitochondrial transcription and resistance of RNA polymerase II dependent nuclear transcription to antiviral ribonucleosides. |
title_full_unstemmed |
Sensitivity of mitochondrial transcription and resistance of RNA polymerase II dependent nuclear transcription to antiviral ribonucleosides. |
title_sort |
sensitivity of mitochondrial transcription and resistance of rna polymerase ii dependent nuclear transcription to antiviral ribonucleosides. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS Pathogens |
issn |
1553-7366 1553-7374 |
publishDate |
2012-01-01 |
description |
Ribonucleoside analogues have potential utility as anti-viral, -parasitic, -bacterial and -cancer agents. However, their clinical applications have been limited by off target effects. Development of antiviral ribonucleosides for treatment of hepatitis C virus (HCV) infection has been hampered by appearance of toxicity during clinical trials that evaded detection during preclinical studies. It is well established that the human mitochondrial DNA polymerase is an off target for deoxyribonucleoside reverse transcriptase inhibitors. Here we test the hypothesis that triphosphorylated metabolites of therapeutic ribonucleoside analogues are substrates for cellular RNA polymerases. We have used ribonucleoside analogues with activity against HCV as model compounds for therapeutic ribonucleosides. We have included ribonucleoside analogues containing 2'-C-methyl, 4'-methyl and 4'-azido substituents that are non-obligate chain terminators of the HCV RNA polymerase. We show that all of the anti-HCV ribonucleoside analogues are substrates for human mitochondrial RNA polymerase (POLRMT) and eukaryotic core RNA polymerase II (Pol II) in vitro. Unexpectedly, analogues containing 2'-C-methyl, 4'-methyl and 4'-azido substituents were inhibitors of POLRMT and Pol II. Importantly, the proofreading activity of TFIIS was capable of excising these analogues from Pol II transcripts. Evaluation of transcription in cells confirmed sensitivity of POLRMT to antiviral ribonucleosides, while Pol II remained predominantly refractory. We introduce a parameter termed the mitovir (mitochondrial dysfunction caused by antiviral ribonucleoside) score that can be readily obtained during preclinical studies that quantifies the mitochondrial toxicity potential of compounds. We suggest the possibility that patients exhibiting adverse effects during clinical trials may be more susceptible to damage by nucleoside analogs because of defects in mitochondrial or nuclear transcription. The paradigm reported here should facilitate development of ribonucleosides with a lower potential for toxicity. |
url |
http://europepmc.org/articles/PMC3499576?pdf=render |
work_keys_str_mv |
AT jamiejarnold sensitivityofmitochondrialtranscriptionandresistanceofrnapolymeraseiidependentnucleartranscriptiontoantiviralribonucleosides AT sureshdsharma sensitivityofmitochondrialtranscriptionandresistanceofrnapolymeraseiidependentnucleartranscriptiontoantiviralribonucleosides AT joyyfeng sensitivityofmitochondrialtranscriptionandresistanceofrnapolymeraseiidependentnucleartranscriptiontoantiviralribonucleosides AT adriansray sensitivityofmitochondrialtranscriptionandresistanceofrnapolymeraseiidependentnucleartranscriptiontoantiviralribonucleosides AT ericdsmidansky sensitivityofmitochondrialtranscriptionandresistanceofrnapolymeraseiidependentnucleartranscriptiontoantiviralribonucleosides AT marialkireeva sensitivityofmitochondrialtranscriptionandresistanceofrnapolymeraseiidependentnucleartranscriptiontoantiviralribonucleosides AT aesopcho sensitivityofmitochondrialtranscriptionandresistanceofrnapolymeraseiidependentnucleartranscriptiontoantiviralribonucleosides AT jasonperry sensitivityofmitochondrialtranscriptionandresistanceofrnapolymeraseiidependentnucleartranscriptiontoantiviralribonucleosides AT jenniferevela sensitivityofmitochondrialtranscriptionandresistanceofrnapolymeraseiidependentnucleartranscriptiontoantiviralribonucleosides AT yeojinpark sensitivityofmitochondrialtranscriptionandresistanceofrnapolymeraseiidependentnucleartranscriptiontoantiviralribonucleosides AT yilixu sensitivityofmitochondrialtranscriptionandresistanceofrnapolymeraseiidependentnucleartranscriptiontoantiviralribonucleosides AT yangtian sensitivityofmitochondrialtranscriptionandresistanceofrnapolymeraseiidependentnucleartranscriptiontoantiviralribonucleosides AT dariusbabusis sensitivityofmitochondrialtranscriptionandresistanceofrnapolymeraseiidependentnucleartranscriptiontoantiviralribonucleosides AT onabarauskus sensitivityofmitochondrialtranscriptionandresistanceofrnapolymeraseiidependentnucleartranscriptiontoantiviralribonucleosides AT blakerpeterson sensitivityofmitochondrialtranscriptionandresistanceofrnapolymeraseiidependentnucleartranscriptiontoantiviralribonucleosides AT averellgnatt sensitivityofmitochondrialtranscriptionandresistanceofrnapolymeraseiidependentnucleartranscriptiontoantiviralribonucleosides AT mikhailkashlev sensitivityofmitochondrialtranscriptionandresistanceofrnapolymeraseiidependentnucleartranscriptiontoantiviralribonucleosides AT weidongzhong sensitivityofmitochondrialtranscriptionandresistanceofrnapolymeraseiidependentnucleartranscriptiontoantiviralribonucleosides AT craigecameron sensitivityofmitochondrialtranscriptionandresistanceofrnapolymeraseiidependentnucleartranscriptiontoantiviralribonucleosides |
_version_ |
1724886180485398528 |